27 February 2020 - Barhemsys is the first and only antiemetic to be approved for the rescue treatment of PONV in patients who have failed prior prophylaxis using current standard of care.

Acacia Pharma announces that the US FDA has approved Barhemsys (amisulpride injection) for the prevention and treatment of PONV in adult patients.

Read Acacia Pharma press release